BTV-3 is spreading through British livestock again, bringing vaccination, movement controls and thousands of disease reports with it. The outbreak also exposes a familiar One Health security problem: surveillance depends upon the people who bear the consequences of reporting.
Bluetongue is moving through British livestock again.
By 24 August 2026, 618 cases of bluetongue virus serotype 3 (BTV-3) had been confirmed in the United Kingdom during the 2026–27 season — 580 in England, 29 in Wales and nine in Scotland. Northern Ireland had recorded no cases during the current season, although cases had occurred there during 2025–26.
Perhaps the more striking number is the one sitting behind the confirmed cases: a further 2,236 potential cases were under investigation in Great Britain — farms where suspicious clinical signs have been reported and investigations are under way. On 23 August alone, another 25 BTV-3 cases were confirmed in England and one in Scotland, all following reports of suspicious clinical signs.
For farmers, this is therefore no longer an abstract disease threat sitting somewhere on a government risk map. It is an active animal-health event involving sick livestock, veterinary decisions, vaccination, testing and changing movement requirements.
For One Health security, however, it raises another question. What happens when the surveillance system depends upon the people who also experience the consequences of activating it?
What exactly is BTV-3?
Bluetongue is a viral disease affecting ruminants, including sheep and cattle, as well as animals such as goats, deer and camelids.
Unlike diseases that spread primarily through direct contact between livestock, bluetongue is principally transmitted by biting Culicoides midges: an infected midge feeds on a susceptible animal and can transmit the virus, and other midges can subsequently acquire it when feeding on infected animals and continue transmission. That means the epidemiology is partly governed by something farmers cannot control — insect activity. Temperature, season and weather affect the behaviour, abundance and capacity of midges to transmit virus; animal movements matter too, because moving an infected animal can introduce virus into an area where competent vectors are present. The resulting control problem is therefore very different from simply isolating an infected herd.
Bluetongue is also not considered a human-health threat. It does not infect people, and food-safety authorities do not regard meat or milk from affected animals as posing a bluetongue risk to consumers. Its importance lies instead in animal health, welfare, agricultural production, trade and the economic resilience of livestock businesses.
That still makes it a One Health security problem. One Health is not restricted to diseases capable of infecting humans: animal disease can alter food production, livelihoods, trade, land use, veterinary capacity and the behaviour of people managing animals, while environmental conditions and vector ecology influence how the disease moves. BTV-3 sits precisely at that intersection.
Why is everybody talking about it now?
The current situation is the continuation of a disease story that began several years ago. BTV-3 emerged in the Netherlands in 2023 and subsequently spread through parts of northern Europe; the first UK BTV incursions for more than 15 years were detected in late 2023, and England subsequently experienced further cases.
The numbers have since increased substantially. Defra records 160 BTV-3 cases in England during the 2024–25 season, together with two cases resulting from high-risk movements into Wales. During 2025–26 there were 348 bluetongue cases in Great Britain, predominantly BTV-3, as well as five confirmed BTV-3 cases in Northern Ireland. The first case of the current 2026–27 season was confirmed on 10 July; by 24 August, the UK total had reached 618 cases.
The geographical picture is also changing. England and Wales are operating country-wide restricted zones, while cases detected in Dumfries and Galloway during August led to the establishment of a temporary control zone in south-west Scotland. This is why livestock keepers are being asked to remain alert.
What does a farmer actually have to do?
Bluetongue is a notifiable disease: if a keeper suspects it, the suspicion must be reported. That sounds straightforward when written in legislation or disease-control guidance, but the practical surveillance system begins with something much less certain — somebody looking at an animal and deciding that what they are seeing might matter.
Clinical signs can include fever, swelling of the face, lips or tongue, mouth lesions, excessive salivation, lameness and other signs of illness, with sheep often experiencing more obvious clinical disease than cattle. A farmer or vet therefore has to recognise that an animal looks wrong, consider bluetongue among the possible explanations and report that suspicion. APHA then assesses the report and, where investigation is required, arranges sampling and diagnostic testing; Defra currently funds diagnostic testing for up to three affected animals where suspicious clinical signs have been reported.
Every confirmed case on the current map therefore begins somewhere with observation. That makes farmers part of Britain’s biological surveillance infrastructure.
Reporting is not a passive act
This matters because reporting suspected disease is sometimes discussed as though information simply enters a surveillance system automatically. It does not: someone produces that information. In passive animal-disease surveillance, the person closest to the animal — a farmer, stockperson or private veterinary surgeon — is often responsible for producing the first signal, so the quality of surveillance depends partly upon whether those people recognise disease, know how to report it and are willing to do so promptly.
This creates a governance issue that extends well beyond bluetongue. Reporting a suspected notifiable disease can create uncertainty for the person making the report: animals may need to be examined or sampled, movements can become more complicated depending upon the disease situation and location, business decisions may have to be postponed, and a farmer may spend time waiting for results while trying to understand what happens next.
None of this means that farmers should avoid reporting — quite the opposite: rapid reporting is essential to effective surveillance. It means that disease-control systems need to be designed around a simple behavioural reality: reporting has a cost to the reporter, even when reporting is clearly the right thing to do.
The lesson from compensation
This connects bluetongue with a much wider question about animal-disease policy. Compensation is often discussed principally as an issue of fairness: if the state orders an animal to be destroyed for disease-control purposes, what should the owner receive? Fairness matters, but compensation can perform another function — it can influence surveillance behaviour.
If reporting suspected disease carries the possibility of substantial uncompensated loss, the system creates a tension between the public interest in rapid disclosure and the private economic interests of the person expected to disclose. That does not mean farmers conceal disease whenever compensation is inadequate, nor should policy assume that they will; it means that good surveillance design should avoid creating unnecessary reasons for hesitation.
Bluetongue demonstrates why the issue is more complicated than simply promising payment for slaughtered animals. In England’s BTV-3 control framework, targeted culling can be considered when infection is first detected in a new area and officials believe removing positive animals could prevent establishment, and government policy provides for market-value payment where animals are culled in that context. Once virus is circulating within local midge populations, however, widespread culling becomes ineffective and disproportionate as a control strategy.
The economic burden of an outbreak can therefore extend far beyond animals formally destroyed by government. Disease itself can cause losses; veterinary intervention, vaccination and movement conditions all have a cost; and breeding decisions, movements of germinal products, markets, shows and movements between differently regulated areas may require additional planning, testing or licensing. The relationship between disease control and farmer incentives is therefore considerably broader than compensation alone — a point we develop in the explainer They Cull Your Herd. What Do You Actually Get?
Vaccination changes the equation
Vaccination is now a central part of BTV-3 risk management. Three BTV-3 vaccines are authorised for use in the UK — Bluevac-3, BULTAVO 3 and Syvazul BTV 3 — and although a veterinary surgeon must prescribe the vaccine, livestock keepers can administer it themselves.
Vaccination does not make the wider disease-control system disappear. The authorised products have claims that differ by species and product, including reductions in viraemia, mortality, clinical signs or lesions, so farmers need to discuss vaccination decisions with their veterinary surgeon rather than treating vaccination as a guarantee that infection cannot occur.
There is also a surveillance component built directly into vaccination. In England, Wales and Scotland, keepers must retain vaccination records for at least five years and report BTV-3 vaccinations within 48 hours, including information such as animal identification and the vaccine used. This creates another potentially valuable stream of disease intelligence.
The outbreak response is therefore generating several overlapping forms of information: suspected disease reports, diagnostic results, confirmed premises, vaccination records, livestock movement information and geographical information about restricted areas. The challenge is ensuring that these signals contribute to a coherent picture.
Movement controls are really information controls too
Movement restrictions are normally understood in physical terms — preventing potentially infected animals from transporting virus into new areas — and that is their immediate epidemiological purpose. Yet movement control also depends heavily upon information: authorities need to know where animals are located, where they are moving, whether the movement crosses a disease-control boundary, whether testing or licensing is required and, increasingly, what vaccination information is associated with those animals.
As of August 2026, the whole of England is within a bluetongue restricted zone, as is Wales; movements within and between those areas are substantially freer than movements into areas operating different controls, while movements into Scotland are subject to specific requirements. Scotland’s detection of BTV-3 during August demonstrates why those boundaries can change.
A disease-control map is therefore not simply a geographical representation of infection. It changes the rules governing the network — and for livestock businesses, that can turn a biological event into a logistical one extremely quickly.
The reporting gap
The most important One Health Security lesson from the current outbreak may therefore sit before the laboratory test. Disease surveillance often concentrates on what happens after a sample enters the system — diagnostic sensitivity, laboratory capacity, genomic analysis, epidemiological modelling and mapping. All are essential. But none can analyse an animal that nobody reports.
The surveillance chain begins with recognition and disclosure. This gives us what might be called the reporting gap: the distance between disease becoming observable and that observation entering the formal surveillance system.
Several things can widen that gap. Clinical signs may be subtle or non-specific; farmers may not initially recognise the disease; veterinary access can vary; reporting procedures may appear complicated; the economic implications of a suspected case may be uncertain; and people may simply wait to see whether an animal improves. A resilient surveillance system therefore needs more than a legal obligation to report — it needs to make prompt reporting the easiest and most rational response.
What would better surveillance look like?
The first requirement is speed. A farmer noticing suspicious signs should know immediately where to report them, what information will be required and what will happen next; APHA’s explanation of the route from reporting through assessment, sampling and laboratory results is valuable precisely because uncertainty about process can itself become a barrier.
The second is feedback. People are more likely to participate effectively in surveillance when information does not disappear into an institutional black box: farmers need to understand what has been found, what it means for their holding and what the wider disease picture looks like.
The third is economic design. Disease-control policy should routinely consider the incentives created by testing, movement restrictions, vaccination requirements and compensation arrangements. The question should not simply be whether a rule is epidemiologically justified, but whether its implementation inadvertently makes rapid disclosure economically difficult.
The fourth is integration. Disease reports, laboratory results, vaccination records, animal movements and vector-risk information should increasingly be treated as components of the same surveillance environment rather than separate administrative datasets. This does not require a giant central database; it requires the ability to connect relevant information quickly enough to understand what the disease is doing.
The farmer is part of the sensor network
It is tempting to imagine modern biological surveillance as increasingly technological: we have PCR, genomic sequencing, modelling, meteorological data, geographical information systems and increasingly sophisticated digital animal records. Yet the current BTV-3 outbreak provides a useful corrective. On 23 August, the newly confirmed cases in England and Scotland had all been tested because suspicious clinical signs were reported. Before the PCR result, there was a person looking at an animal.
That person is part of the surveillance architecture. If One Health security is concerned with detecting biological threats earlier, then farmers, veterinary surgeons and animal keepers should not simply be regarded as people who must comply with disease-control rules after an outbreak has been detected. They are part of the detection system itself — and the effectiveness of that system consequently depends upon trust, communication, practical support and economic incentives as much as laboratory capability.
Beyond bluetongue
Bluetongue will eventually move out of the headlines. The underlying governance problem will remain. African swine fever, foot-and-mouth disease, avian influenza and emerging livestock infections all create different combinations of reporting, testing, movement restrictions, vaccination, culling, compensation and commercial disruption. The details differ enormously between diseases, which is why the same control strategy cannot simply be transferred from one pathogen to another — but the underlying behavioural question is remarkably consistent. Does the system make early reporting easier, or does it accidentally make waiting attractive?
That question belongs alongside diagnostics, epidemiology and biosecurity in disease preparedness. The lesson of After the Cull was that compensation should not be understood only as payment after a loss; it can form part of the infrastructure that sustains trust and cooperation during animal-disease control. BTV-3 extends that argument: where mass culling is neither appropriate nor useful, the question becomes broader — how do we design the entire economic and administrative experience of disease reporting so that the interests of the farmer and the interests of surveillance remain aligned?
The current outbreak shows why that matters. Britain now has sophisticated laboratories, vaccination, movement controls and increasingly detailed disease surveillance. But the first warning can still begin with somebody standing in a field, noticing that a sheep does not look right, and deciding whether to pick up the telephone.
That decision is part of biosecurity. And the systems surrounding it deserve as much attention as the test that follows.
Related One Health Security analysis
This analysis develops themes from After the Cull: Foot-and-Mouth Disease, Rural Trauma and the Long Memory of Outbreak Control and the explainer They Cull Your Herd. What Do You Actually Get?, and connects to the wider argument in Trust Is Biosecurity Infrastructure and Salmonella and the Governance Gap.
Related work. The practical problem of connecting on-farm observations, vaccination records and movements into a single trustworthy record — from the farm through to regulatory reporting — is what The BioChain is building through its HerdWare livestock-biosecurity application.
References
- Department for Environment, Food & Rural Affairs and Animal and Plant Health Agency (2026). Bluetongue: latest situation. GOV.UK, updated 23 August 2026.
- Animal and Plant Health Agency (2026). Bluetongue: how to spot and report it. GOV.UK.
- Department for Environment, Food & Rural Affairs and Veterinary Medicines Directorate (2026). Bluetongue serotype 3 (BTV-3) vaccination. GOV.UK.
- Department for Environment, Food & Rural Affairs (2026). Livestock keepers urged to be on high alert and consider vaccination as bluetongue cases rise. GOV.UK.
- Department for Environment, Food & Rural Affairs and Animal and Plant Health Agency (2026). Bluetongue virus in Europe. GOV.UK.
- Department for Environment, Food & Rural Affairs (2024). Disease control framework for bluetongue virus serotype 3 in England. GOV.UK.
- Department for Environment, Food & Rural Affairs and Animal and Plant Health Agency. Compensation for animals culled to control animal diseases. GOV.UK.
Key Takeaways
- BTV-3 is spreading through British livestock again — but every confirmed case begins with a farmer or vet noticing something wrong and choosing to report it.
- That makes farmers part of the surveillance system, not just subjects of disease control — so surveillance depends on trust, feedback, practical support and economic incentives, not only laboratory capacity.
- The "reporting gap" — the distance between disease becoming observable and that observation entering the system — widens when reporting carries an uncertain or uncompensated cost.
- Where mass culling is neither useful nor appropriate, as with an insect-borne disease, the design question becomes how to keep the farmer's interests and the surveillance system's interests aligned.
